findmyKOL
Clinical trialNCT06831526RecruitingEarly phase 1Interventional

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

SponsorWashington University School of MedicineEnrollment12Glioblastoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Abraham Snyder, M.D.Albert Kim, M.D., Ph.D.Ananth Vellimana, M.D.Chongliang Luo, Ph.D.Chun-Kan Chen, Ph.D.Dimitrios Mathios, M.D.Eric Leuthardt, M.D.Greg Zipfel, M.D.Jiayi Huang, M.D.Joshua Dowling, M.D.Joshua Shimony, M.D.Milan Chheda, M.D., Ph.D.Nikhil Rammohan, M.D., Ph.D.Omar Butt, M.D., Ph.D.Robert Fucetola, Ph.D.Tammie Benzinger, M.D., Ph.D.Tanner Johanns, M.D., Ph.D.Timothy Mitchell, Ph.D.Zhihua Liu, Ph.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Nov 2025
Primary completion
28 Feb 2029
Completion
31 Aug 2030
Last update posted
29 May 2026
Registered enrollment
12
Registry id
NCT06831526

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.